Skip to main content

Are We at the Dawn of “Insulin Socialism”?

Leigh Phillips Jacobin
The high cost of insulin is one of the great injustices of the US health care system. But now, states like California are looking at directly manufacturing this essential medicine — a potentially massive win for both patients and left-wing politics.

Curing Cancer: Conquering Disease or Creating Profit?

Jake Bernstein/Dean Baker Pro Publica/CEPR
How Big Pharma’s focus on blockbuster cancer drugs and the use of patents to maintain monopoly control of drug prices squeezes out research and research models and methods leading to potential treatments that are more affordable.
Subscribe to pharmaceutical profits